Inclusion and participation of older adults from underrepresented populations in cognitive aging and Alzheimer's disease-related research
Inclusion and participation of older adults from underrepresented populations in cognitive aging and Alzheimer's disease-related research
批准号:
10529942
负责人:
Miriam Ashford
金额:
$0.25万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-30 至 2024-09-29
关键词:
AffectAgeAgingAlzheimer&aposs DiseaseAreaAwardBehavior TherapyBehavioral SymptomsBiological MarkersBiometryBrainBrain Health RegistryCharacteristicsChronicClinicClinicalClinical ResearchClinical TrialsCognitive agingCollectionComplementDataData SetDatabasesDevelopmentDiseaseEducationElderlyEligibility DeterminationEnrollmentEthicsEthnic OriginFailureFamilyFellowshipFutureGenderGeneticGoalsHealth and Retirement StudyIndividualInterventionKnowledgeLeadMedicalModelingMoodsObservational StudyOccupationsParentsParticipantPhasePopulationPopulation HeterogeneityPopulation ResearchPreventionPsychologyPublic HealthRaceRecording of previous eventsRegistriesResearchResearch DesignResearch Project GrantsResearch TrainingRisk FactorsRoleRuralSamplingSampling StudiesSocioeconomic StatusSourceTargeted ResearchTrainingUnderrepresented Populationsbasebiopsychosocialbiopsychosocial factorburden of illnesscareercareer developmentcognitive functioncohortcomorbiditycomplex datadesigndigitaldisease disparityevidence baseexperiencehealth disparityimprovedinnovationlow socioeconomic statusnegative affectneuroimagingnovelpopulation basedracial and ethnicrecruitsexsocial culturesociodemographicssocioeconomic disadvantagesocioeconomicstrial designvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT (parent award)
Alzheimer’s disease (AD) is a major public health burden and disproportionately affects underrepresented
populations (URPs), including underrepresented ethnoracial groups and those with low socioeconomic status.
URPs are chronically underrepresented in AD clinical research, which has substantial scientific and ethical
ramifications. The separate and interacting contributions of sociodemographic and other factors to multiple
levels of research participation, including enrollment, retention, and study task completion, are not well
understood. Based on current health disparities theoretical frameworks, like the biopsychosociocultural model,
multiple factors need to be considered. Therefore, the overall scientific objective of this proposal is to
investigate multiple biopsychosocial factors affecting inclusion and participation of URPs in different research
settings with a specific focus on ethnoracial and low educational attainment URPs. An innovative approach will
be used to examine these important hypotheses by leveraging three existing cohorts from different research
settings: (1) the Brain Health Registry (BHR), a cognitive aging-related longitudinal research registry,
N>70,000, (2) the Alzheimer’s Disease Initiative (ADNI), an in-clinic observational AD study, N>2,000, and (3)
the Health and Retirement Study (HRS), a population-based aging study, N>20,000. The two main hypotheses
are (1) Associations between URP status and research participation are affected by multiple
biopsychosociocultural factors. We will examine the moderating role of biopsychosociocultural factors on URP
research participation in BHR and ADNI; (2) Eligibility criteria of AD trials contribute to underrepresentation of
URPs. We will apply a list of current AD trial eligibility criteria to the population-based HRS sample to
determine and statistically compare sociodemographic characteristics of eligible/ineligible participants. We will
further explore the contributions of trial design characteristics on eligibility. This project is both highly novel and
significant as it will be the first to conduct an in-depth examination of multiple biopsychosociocultural factors
affecting URP inclusion and participation in a variety of different settings. Improved understanding of the role of
biosychosociocultural factors on URP research participation is critical to elucidate sources of research
participation disparities frequently affecting URPs. Thus, results are likely to have important public health
implications, as this study may inform targeted research inclusion and engagement strategies to improve
diversity. This research plan is complemented by a training plan that builds on the candidate’s recent transition
from clinical research psychology to the aging and AD field, and therefore includes training in (1) cognitive
aging/AD and related clinical trials; (2) complex data sets analysis, advanced biostatistics; (3) AD disparities;
(4) URP research participation disparities; (5) professional development. The combined research and training
plans will prepare the candidate for a successful independent research career focused on increasing diversity
in cognitive aging and AD research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inclusion and participation of older adults from underrepresented populations in cognitive aging and Alzheimer's disease-related research
-
批准号:10230462
-
项目类别:
-
资助金额:$6.91万
-
财政年份:2021
-
负责人:Miriam Ashford
-
依托单位:
Inclusion and participation of older adults from underrepresented populations in cognitive aging and Alzheimer's disease-related research
-
批准号:10516011
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2021
-
负责人:Miriam Ashford
-
依托单位:
Inclusion and participation of older adults from underrepresented populations in cognitive aging and Alzheimer's disease-related research
-
批准号:10677807
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2021
-
负责人:Miriam Ashford
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: